Real-time PCR is highly sensitive. That sensitivity makes qPCR valuable for low-level target detection, but it also means that trace contamination, nonspecific products or incorrectly interpreted fluorescence can be reported as a positive result.

Begin with three questions:
  1. Did the intended target genuinely amplify?
  2. Were the negative controls valid?
  3. Does the amplification curve have the expected shape?

1. Carryover and cross-contamination

Target DNA, high-positive specimens and previously amplified PCR products can contaminate reagents, gloves, pipettes, benches or adjacent wells. Amplification in the no-template control or a spatial cluster beside a strong positive sample should prompt a contamination investigation.

  • Prepare reactions in a clean pre-amplification area.
  • Use aerosol-resistant tips and dedicated equipment.
  • Add positive controls last.
  • Replace suspect water, primers, probes and master mix.
  • Do not open completed amplification plates in the setup area.

2. Primer-dimers and nonspecific amplification

SYBR Green detects any double-stranded DNA, including primer-dimers and off-target amplicons. Late amplification, inconsistent replicates or unexpected melt peaks may indicate that the fluorescence is not generated by the intended product.

  • Review primer complementarity and predicted off-target binding.
  • Optimize primer concentration and annealing temperature.
  • Compare melt temperatures with the expected control.
  • Confirm suspicious products by gel electrophoresis or sequencing when appropriate.

3. Genomic DNA in RT-qPCR

Residual genomic DNA can be amplified during gene-expression testing. No-reverse-transcriptase controls, effective DNase treatment and primers spanning exon–exon junctions can help distinguish cDNA-derived signal from genomic contamination.

4. Cross-reactivity and poor assay specificity

A technically successful reaction may still detect a related organism, homologous gene, pseudogene or host sequence. Analytical specificity should be evaluated using in-silico analysis and an appropriate exclusivity panel.

5. Baseline and threshold settings

A Cq or Ct value should not be accepted without reviewing the curve. Thresholds placed within baseline noise can assign a value to a non-sigmoidal fluorescence fluctuation. A convincing curve generally has a stable baseline, a clear exponential phase and reasonable agreement between replicates.

For validated clinical assays, manual threshold changes should only be made when permitted by the approved procedure and documented according to laboratory requirements.

6. Bubbles, condensation and optical artefacts

QuantStudio systems measure fluorescence through the optical plate surface. Bubbles, fingerprints, dust, condensation, damaged wells or poorly applied optical film can cause spikes, abnormal backgrounds or isolated irregular curves.

  • Centrifuge plates before loading.
  • Inspect wells for bubbles.
  • Use compatible optical plates and seals.
  • Keep the optical surface clean and dry.

7. Evaporation and poor sealing

Evaporation changes reaction volume and reagent concentration. Edge wells, inconsistent technical replicates, reduced post-run volume or visible condensation can indicate a sealing problem.

8. Pipetting and plate-map errors

Positive control added to the wrong well, reversed plate orientation, incorrect sample labels or a reused experiment template can produce an apparent false positive. Compare the physical plate, worksheet and electronic layout before repeating the assay.

9. Reporter and passive-reference configuration

The reporter dye, target assignment and passive-reference setting must match the assay chemistry. Incorrect ROX or detector configuration may lead to unusual normalization or analysis.

10. Calibration and maintenance

Instrument-related problems become more likely when abnormalities affect many wells, unrelated assays or consecutive runs. Review calibration status, maintenance records, multicomponent plots and software flags before concluding that the assay chemistry is responsible.

A practical troubleshooting sequence

  1. Review the no-template, extraction-negative, positive and internal controls.
  2. Inspect the curve shape—not only the reported Cq.
  3. Look for plate-position and adjacency patterns.
  4. Review melt curves or confirm product identity.
  5. Verify threshold, baseline, reporter and sample assignments.
  6. Repeat from the same extraction or original specimen using fresh reagents when required.

When should a positive result be questioned?

  • A negative control amplifies.
  • Only one technical replicate is positive.
  • The curve lacks a clear exponential phase.
  • The signal is close to the validated limit of detection.
  • The melt profile differs from the expected product.
  • The result cannot be reproduced.

Late amplification is not automatically false. It may reflect a genuine low-concentration target, stochastic detection near the limit of detection, contamination, primer-dimer formation or background noise. Interpretation must follow the assay’s validated controls, cutoffs and repeat rules.

Conclusion

False-positive PCR results can originate at several stages—from specimen and reagent handling to amplification chemistry, plate setup and software analysis. Controls, curve shape, replicate agreement, melt profile, plate position and validation criteria should be considered together before a result is accepted or rejected.

Selected resources

  1. MIQE 2.0 guidelines
  2. Thermo Fisher Scientific: Real-time PCR troubleshooting
  3. Nonspecific amplification in quantitative PCR
Disclaimer: This article is for scientific and educational purposes. Diagnostic results should be interpreted only within an appropriately validated laboratory workflow.